Monday, March 17, 2025

Precision medicine company falls into administration

Oncimmune, a precision medicine company based in Leeds, has fallen into administration.

It follows attempts by the business to sell its German trading subsidiary and a failure to raise additional capital required to meet the company’s short term funding needs.

Oncimmune has concluded that there are no further options available to extend its cash runway and that the firm should therefore be placed into administration.

In a statement Oncimmune said: “Despite a comprehensive sale process and positive interest in the business it has unfortunately not been possible to secure a buyer for the Company’s trading subsidiary, Oncimmune Germany GmbH. It has also not been possible to raise the additional capital required to meet the Company’s short term funding needs.

“In light of this, and after extensive consideration of the Company’s current financial situation as well as the resulting creditor position, the Board has regrettably concluded that there are no further options available to the Company to extend its cash runway and that the Group should therefore be placed into administration in order to preserve the value of the business for creditors.

“Accordingly, a notice will be filed with the Court today notifying the directors’ intention to appoint Managing Directors from Alvarez & Marsal Europe LLP as administrators of the Company as soon as reasonably practicable.

“Consequently, the Company has requested a suspension in the trading of its ordinary shares on AIM, which will become effective from 7.30am on 17 March 2025.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemichaving a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.








Latest news

Related news